Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

First reported by CNBC 1 source
Read at CNBC(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. CNBC

    Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction (opens CNBC in a new tab)

    The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

Something wrong with how we've grouped or summarised this story? Report a problem